Figure 1.
Cumulative incidence of venous thromboembolism of pancreatic cancer patients with different levels of active plasminogen activator inhibitor 1. Low levels (dashed line) defined as patients with active PAI-1 levels below the median; high levels (solid line) defined as active PAI-1 levels at or above the median.